Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018.

Michael B Streiff,Bjorn Holmstrom,Dana Angelini,Aneel Ashrani,Paula L Bockenstedt,Carolyn Chesney,John Fanikos, Randolph B Fenninger,Annemarie E Fogerty,Shuwei Gao,Samuel Z Goldhaber,Krishna Gundabolu,Paul Hendrie,Alfred I Lee,Jason T Lee,Janelle Mann,Brandon McMahon,Michael M Millenson,Colleen Morton,Thomas L Ortel,Sadat Ozair,Rita Paschal,Sanford Shattil,Tanya Siddiqi,Kristi J Smock,Gerald Soff,Tzu-Fei Wang,Eliot Williams,Anaadriana Zakarija,Lydia Hammond,Mary A Dwyer,Anita M Engh

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK（2018）

Cited 210|Views31
No score
Abstract
Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity and mortality. VTE prevention and treatment are more complex in patients with cancer. The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of VTE in adult patients diagnosed with cancer or in whom cancer is clinically suspected. These NCCN Guidelines Insights explain recent changes in anticoagulants recommended for the treatment of cancer-associated VTE.
More
Translated text
Key words
cancer-associated
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined